文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新型醛糖还原酶抑制剂N-[4-(苯甲酰氨基)苯基磺酰基]甘氨酸前药的体外水解、渗透性及眼部摄取情况

In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.

作者信息

Sunkara G, Deruiter J, Clark C R, Kompella U B

机构信息

College of Pharmacy, University of Nebraska Medical Center, Omaha, 68198-6025, USA.

出版信息

J Pharm Pharmacol. 2000 Sep;52(9):1113-22. doi: 10.1211/0022357001774877.


DOI:10.1211/0022357001774877
PMID:11045892
Abstract

To enhance the ocular uptake of N-[4-(benzoylamino)phenylsulfonyl]glycine (BAPSG), two ester (methyl and isopropyl) prodrugs were synthesized and evaluated for their stability in various buffers (pH 1-9), hydrolysis in rabbit ocular tissues (cornea, conjunctiva, iris-ciliary body, lens, aqueous humor, and vitreous humor), transport across cornea and conjunctiva, and in-vivo uptake following topical administration. Over the pH range of 1-9, the rate constants for degradation ranged from 5.67 to 218.9 x 10(-3) h(-1) for the methyl ester and from 3.14 to 4.45 x 10(-3) h(-1) for the isopropyl ester. At all pH conditions, the isopropyl ester was more stable when compared with the methyl ester. A change in buffer concentration at pH 7.4 did not influence the stability of the prodrugs. The prodrugs were rapidly hydrolysed in the tissue homogenates, with the rate constants for hydrolysis ranging from 1.98 to 7.2x 10(-3) min(-1) for the methyl ester and 3.32 to 6.53 x 10(-3) min(-1) for the isopropyl ester. The in-vitro permeability of the methyl ester was less than the parent drug across cornea and conjunctiva. Isopropyl ester levels were not detectable in the receiver chamber even at the end of the 4-h transport study. Following topical administration of BAPSG and the two prodrugs at a dose of 60 microg/eye, the lowest levels were seen in vitreous humor for parent compound and its methyl ester. In general, the tissue uptake of methyl ester was less than BAPSG. Isopropyl ester levels were below detection limits in all the ocular tissues. Lipophilic ester prodrugs of BAPSG showed good aqueous solution stability in tissue homogenates. However, these prodrugs lacking the free carboxylate anion exhibited reduced in-vitro permeability and in-vivo uptake, suggesting the importance of free carboxylate anion in the delivery of BAPSG.

摘要

为提高N-[4-(苯甲酰氨基)苯基磺酰基]甘氨酸(BAPSG)的眼部摄取量,合成了两种酯(甲酯和异丙酯)前药,并评估了它们在各种缓冲液(pH 1-9)中的稳定性、在兔眼组织(角膜、结膜、虹膜睫状体、晶状体、房水和玻璃体)中的水解情况、跨角膜和结膜的转运以及局部给药后的体内摄取。在pH 1-9范围内,甲酯的降解速率常数为5.67至218.9×10⁻³ h⁻¹,异丙酯为3.14至4.45×10⁻³ h⁻¹。在所有pH条件下,与甲酯相比,异丙酯更稳定。pH 7.4时缓冲液浓度的变化不影响前药的稳定性。前药在组织匀浆中迅速水解,甲酯的水解速率常数为1.98至7.2×10⁻³ min⁻¹,异丙酯为3.32至6.53×10⁻³ min⁻¹。甲酯的体外渗透率低于母体药物跨角膜和结膜的渗透率。即使在4小时转运研究结束时,接受室中也检测不到异丙酯水平。以60 μg/眼的剂量局部给予BAPSG和两种前药后,母体化合物及其甲酯在玻璃体中的水平最低。一般来说,甲酯的组织摄取量低于BAPSG。异丙酯水平在所有眼组织中均低于检测限。BAPSG的亲脂性酯前药在组织匀浆中显示出良好的水溶液稳定性。然而,这些缺乏游离羧酸根阴离子的前药表现出体外渗透率和体内摄取量降低,表明游离羧酸根阴离子在BAPSG递送中的重要性。

相似文献

[1]
In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.

J Pharm Pharmacol. 2000-9

[2]
Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.

J Pharm Pharmacol. 2004-3

[3]
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Brain Res Bull. 2009-9-15

[4]
Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.

Mol Pharm. 2012-10-11

[5]
In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.

Exp Eye Res. 1996-10

[6]
A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Pharm Res. 2002-3

[7]
Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.

J Pharm Sci. 1997-10

[8]
In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye.

J Ocul Pharmacol Ther. 2001-4

[9]
On the prodrug potential of novel aldose reductase inhibitors with diphenylmethyleneaminooxycarboxylic acid structure.

Eur J Pharm Sci. 2002-2

[10]
Prodrugs of 5-iodo-2'-deoxyuridine for enhanced ocular transport.

Pharm Res. 1989-10

引用本文的文献

[1]
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Brain Res Bull. 2009-9-15

[2]
Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.

J Pharm Pharmacol. 2004-3

[3]
A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Pharm Res. 2002-3

[4]
Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor.

Pharm Res. 2001-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索